Literature DB >> 10681462

Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation.

A Poltorak1, P Ricciardi-Castagnoli, S Citterio, B Beutler.   

Abstract

Some mammalian species show an ability to discriminate between different lipopolysaccharide (LPS) partial structures (for example, lipid A and its congener LA-14-PP, which lacks secondary acyl chains), whereas others do not. Using a novel genetic complementation system involving the transduction of immortalized macrophages from genetically unresponsive C3H/HeJ mice, we now have shown that the species-dependent discrimination between intact LPS and tetra-acyl LPS partial structures is fully attributable to the species origin of Toll-like receptor 4 (Tlr4), an essential membrane-spanning component of the mammalian LPS sensor. Because Tlr4 interprets the chemical structure of an LPS molecule, we conclude that LPS must achieve close physical proximity with Tlr4 in the course of signal transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681462      PMCID: PMC15771          DOI: 10.1073/pnas.040565397

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

2.  Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A.

Authors:  C Galanos; V Lehmann; O Lüderitz; E T Rietschel; O Westphal; H Brade; L Brade; M A Freudenberg; T Hansen-Hagge; T Lüderitz
Journal:  Eur J Biochem       Date:  1984-04-16

Review 3.  Genetic control of resistance to infection in mice.

Authors:  D L Rosenstreich; A C Weinblatt; A D O'Brien
Journal:  Crit Rev Immunol       Date:  1982-06       Impact factor: 2.214

4.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

5.  Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor.

Authors:  X Du; A Poltorak; M Silva; B Beutler
Journal:  Blood Cells Mol Dis       Date:  1999 Oct-Dec       Impact factor: 3.039

6.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.

Authors:  S Kanegasaki; Y Kojima; M Matsuura; J Y Homma; A Yamamoto; Y Kumazawa; K Tanamoto; T Yasuda; T Tsumita; M Imoto
Journal:  Eur J Biochem       Date:  1984-09-03

8.  Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.

Authors:  M A Freudenberg; D Keppler; C Galanos
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

9.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim.

Authors:  S M Michalek; R N Moore; J R McGhee; D L Rosenstreich; S E Mergenhagen
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

10.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.

Authors:  D T Golenbock; R Y Hampton; N Qureshi; K Takayama; C R Raetz
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

View more
  96 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.

Authors:  D Filipp; K Alizadeh-Khiavi; C Richardson; A Palma; N Paredes; O Takeuchi; S Akira; M Julius
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

3.  Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium.

Authors:  Elke Cario; Dennis Brown; Mary McKee; Kathryn Lynch-Devaney; Guido Gerken; Daniel K Podolsky
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 4.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

Review 5.  Present concepts on the inflammatory modulators with special reference to cytokines.

Authors:  A S J P A M Van Miert
Journal:  Vet Res Commun       Date:  2002-02       Impact factor: 2.459

Review 6.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 7.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

Review 8.  Toll-like receptors: molecular mechanisms of the mammalian immune response.

Authors:  H D Brightbill; R L Modlin
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

9.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 10.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.